V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158892 | 20060929 | 1.65 | 80.3 | Palliative (P) | 2016-06-02 | 2016-06-03 | ECX | N | N | ECX | 101215929 |
| 20158894 | 20060930 | 1.58 | 58 | Palliative (P) | 2016-12-22 | 2016-12-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100264049 |
| 20158898 | 20060931 | 1.77 | 52 | Neo-adjuvant (N) | 2017-09-18 | 2017-10-03 | ECX | null | N | ECX | 101289371 |
| 20158899 | 20060932 | 1.59 | 75.4 | Neo-adjuvant (N) | 2017-09-26 | 2017-10-02 | ECX | N | N | ECX | 100479826 |
| 20158900 | 20060933 | 1.57 | 75.3 | Adjuvant (A) | 2016-02-11 | 2016-03-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100667751 |
| 20158904 | 20060934 | 1.73 | 90.9 | Palliative (P) | 2016-04-19 | 2016-04-26 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100566449 |
| 20158907 | 20060935 | 1.78 | 76.8 | Adjuvant (A) | 2016-06-21 | 2016-06-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100728326 |
| 20158908 | 20060936 | 1.84 | 84.6 | Adjuvant (A) | 2017-06-11 | 2017-06-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100580299 |
| 20158909 | 20060937 | null | 73.1 | Adjuvant (A) | 2018-02-27 | 2018-03-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101235293 |
| 20158910 | 20060938 | 1.66 | 78.5 | null | 2016-12-12 | 2016-12-17 | ECX | null | N | ECX | 100654018 |
| 20158911 | 20060939 | 1.47 | 81.1 | Curative (C) | 2017-11-02 | 2017-11-18 | ECX | 02 | N | ECX | 101554418 |
| 20158919 | 20060940 | 1.63 | 67.8 | Palliative (P) | 2016-04-16 | 2016-05-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101782792 |
| 20158920 | 20060941 | null | null | Neo-adjuvant (N) | 2016-09-02 | 2016-09-16 | ECX | N | N | ECX | 100864764 |
| 20158922 | 20060942 | 1.76 | 90 | Adjuvant (A) | 2019-11-17 | 2019-11-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100519056 |
| 20158924 | 20060943 | 1.76 | 113 | Neo-adjuvant (N) | 2019-02-07 | 2019-03-08 | ECX | N | N | ECX | 101509498 |
| 20158926 | 20060944 | 1.76 | 94 | Adjuvant (A) | 2017-12-01 | 2017-12-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100344100 |
| 20158927 | 20060945 | null | null | Neo-adjuvant (N) | 2018-03-21 | 2018-03-30 | ECX | N | N | ECX | 100233996 |
| 20158929 | 20060946 | 1.77 | 81.8 | Palliative (P) | 2018-03-05 | 2018-03-05 | ECX | 02 | N | ECX | 100042609 |
| 20158932 | 20060947 | 1.66 | 78 | Neo-adjuvant (N) | 2017-03-23 | 2017-03-26 | ECX | N | N | ECX | 101673333 |
| 20158933 | 20060948 | 1.59 | 47.6 | Palliative (P) | 2019-11-03 | 2019-11-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100439225 |
| 20158937 | 20060949 | 1.6 | 67.5 | Palliative (P) | 2017-10-25 | 2017-11-08 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101633590 |
| 20158942 | 20060950 | 1.52 | 58.2 | null | null | 2018-02-09 | ECX | Y | N | ECX | 100911438 |
| 20158944 | 20060951 | 1.77 | 47.3 | Palliative (P) | 2018-06-09 | 2018-06-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100900656 |
| 20158945 | 20060952 | 1.62 | 56.3 | Adjuvant (A) | 2017-10-27 | 2017-11-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100165947 |
| 20158946 | 20060953 | 1.6 | 52.9 | Neo-adjuvant (N) | 2016-09-02 | 2016-09-03 | ECX | N | N | ECX | 100949396 |
| 20158947 | 20060954 | 1.61 | 50 | Neo-adjuvant (N) | 2016-04-29 | 2016-05-25 | ECX | 02 | N | ECX | 100483345 |
| 20158948 | 20060955 | 1.57 | 56.9 | null | 2018-05-17 | 2018-07-06 | ECX | N | null | ECX | 101046820 |
| 20158950 | 20060956 | 1.7 | 90.5 | Curative (C) | 2018-10-31 | 2018-11-17 | ECX | N | N | ECX | 100900619 |
| 20158952 | 20060957 | 1.73 | 51.8 | Curative (C) | 2019-08-05 | 2019-08-26 | ECX | N | N | ECX | 101613250 |
| 20158953 | 20060958 | 1.67 | 70.1 | Adjuvant (A) | 2016-09-09 | 2016-09-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101255698 |
| 20158954 | 20060959 | 1.67 | 53.7 | Palliative (P) | 2018-04-06 | 2018-04-12 | ECX | N | N | ECX | 100374597 |
| 20158956 | 20060960 | 1.81 | 50.8 | 03 | 2018-05-27 | 2018-05-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101467311 |
| 20158959 | 20060961 | 1.81 | 75.3 | Palliative (P) | 2018-05-16 | 2018-06-04 | ECX | N | null | ECX | 100947621 |
| 20158966 | 20060962 | 1.68 | 69.15 | Adjuvant (A) | 2018-03-06 | 2018-04-08 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100351240 |
| 20158968 | 20060963 | null | 83.9 | Adjuvant (A) | 2019-07-20 | 2019-08-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100973454 |
| 20158972 | 20060964 | 1.53 | 50.4 | Neo-adjuvant (N) | 2020-01-28 | 2020-02-16 | ECX | N | N | ECX | 101475029 |
| 20158975 | 20060965 | 1.69 | 49.1 | Palliative (P) | 2017-06-22 | 2017-07-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101597049 |
| 20158976 | 20060966 | 1.62 | 82.2 | Neo-adjuvant (N) | 2018-10-23 | 2018-11-03 | ECX | N | N | ECX | 100141578 |
| 20158977 | 20060967 | 1.72 | 56 | Adjuvant (A) | 2017-11-13 | 2017-11-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100159433 |
| 20158978 | 20060968 | 1.65 | 75.3 | Adjuvant (A) | 2017-04-07 | 2017-04-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101752813 |
| 20158979 | 20060969 | 1.7 | 68.3 | Adjuvant (A) | 2018-01-16 | 2018-02-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101327959 |
| 20158980 | 20060970 | 1.61 | 63 | Adjuvant (A) | 2017-03-15 | 2017-03-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100490875 |
| 20158984 | 20060971 | 1.69 | 66.4 | Palliative (P) | 2016-02-17 | 2016-03-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101312026 |
| 20158985 | 20060972 | 1.71 | 74 | Palliative (P) | 2016-12-11 | 2016-12-25 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100395886 |
| 20158986 | 20060973 | 1.6 | 58 | Neo-adjuvant (N) | 2020-01-27 | 2020-02-02 | ECX | N | N | ECX | 100933967 |
| 20158987 | 20060974 | 1.76 | 73.6 | Neo-adjuvant (N) | 2016-06-28 | 2016-07-09 | ECX | N | N | ECX | 101048853 |
| 20158988 | 20060975 | 1.7 | 70 | Neo-adjuvant (N) | 2018-09-15 | 2018-09-17 | ECX | 02 | N | ECX | 101399744 |
| 20158989 | 20060976 | 1.52 | 78.3 | Curative (C) | 2019-05-25 | 2019-05-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100208040 |
| 20158990 | 20060977 | 1.78 | 86 | Neo-adjuvant (N) | 2016-05-31 | 2016-05-31 | ECX | N | null | ECX | 100802522 |
| 20158991 | 20060978 | 1.54 | 94.75 | Adjuvant (A) | 2018-06-03 | 2018-06-18 | ECX | N | N | ECX | 100579730 |